Retrospective Analyses of TrakStar Database

NCT06917339 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 156000

Last updated 2026-04-09

No results posted yet for this study

Summary

In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.

Conditions

  • Depression
  • Obsessive-Compulsive Disorder
  • Anxiety Depression

Interventions

DEVICE

NeuroStar Advanced TMS Therapy System

non-invasive brain stimulation device

Sponsors & Collaborators

  • Neuronetics

    lead OTHER

Principal Investigators

  • Eleanor Cole, PhD · Neuronetics

Eligibility

Min Age
5 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-25
Primary Completion
2035-12-31
Completion
2035-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06917339 on ClinicalTrials.gov